T-Cell Responses in Merkel Cell Carcinoma: Implications for Improved Immune Checkpoint Blockade and Other Therapeutic Options
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: International Journal of Molecular Sciences 22.16 (2021): 8679.
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2021
- Creator
-
Gehrcken, Laura
Sauerer, Tatjana
Schaft, Niels
Dörrie, Jan
- DOI
-
10.3390/ijms22168679
- URN
-
urn:nbn:de:bvb:29-opus4-194621
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:43 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gehrcken, Laura
- Sauerer, Tatjana
- Schaft, Niels
- Dörrie, Jan
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2021
Other Objects (12)
ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma
T-cell receptor avidity of polyclonal CD8+ T-cell populations
Human T-cell clones
CAR T-Cell therapy
Renal cell carcinoma with sarcomatoid features: finally new therapeutic hope?
The immunopeptidomic landscape of clear cell renal cell carcinoma : identification and characterization of T-cell epitopes for immunotherapeutic approaches
The T-cell receptor and it's signaling in T-cell prolymphocytic Leukemia
Identification of Suitable T-Cell Subsets for Personalized Antiviral T-Cell Immunotherapy
Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine
Human T-cell leukemia virus
Stochastic T-cell fate decisions
ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma
T-cell receptor avidity of polyclonal CD8+ T-cell populations
Human T-cell clones
CAR T-Cell therapy
Renal cell carcinoma with sarcomatoid features: finally new therapeutic hope?
The immunopeptidomic landscape of clear cell renal cell carcinoma : identification and characterization of T-cell epitopes for immunotherapeutic approaches
The T-cell receptor and it's signaling in T-cell prolymphocytic Leukemia
Identification of Suitable T-Cell Subsets for Personalized Antiviral T-Cell Immunotherapy
Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine
Human T-cell leukemia virus
Stochastic T-cell fate decisions
ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma
T-cell receptor avidity of polyclonal CD8+ T-cell populations
Human T-cell clones
CAR T-Cell therapy
Renal cell carcinoma with sarcomatoid features: finally new therapeutic hope?
The immunopeptidomic landscape of clear cell renal cell carcinoma : identification and characterization of T-cell epitopes for immunotherapeutic approaches
The T-cell receptor and it's signaling in T-cell prolymphocytic Leukemia
Identification of Suitable T-Cell Subsets for Personalized Antiviral T-Cell Immunotherapy
Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine
Human T-cell leukemia virus